1."More companies are doomed because of over-extending, and not focusing on that which they are good at"...I thought they were 'good' at enzyme technology? Isn't that focus? Proven and established as words, can be interchangeable...the products have been 'proven' to work and from what I read in the company's PR's the product is moving into the market place as we speak. I.e. Phase 1 is complete and we move onto the GC2000. Doesn't sound like overextending to me. Sounds more like eating a cookie one bite at a time. But, that's just me.
2."Why not establish the other "proven" products before attacking prototypes?" The enzyme technology is proven, it is allegedly their core business focus. I also think this 'prototype' thing is really being twisted around out of it's context. From some of the DD that has been done by some of the folks here, it appears that EVERY GC2000 produced will actually be a 'prototype' due to the fact that each GC2000 will be tailored to suit an individual customer's needs.
3."they've known about the costs associated with the GC2000 for years, not 2 months. LOL" Where did you get the information that they've known for years about the costs associated with the GC2000? I haven't seen that specific time frame. However, if they did perhaps that was one of the motivating factors for going public.
-Dave-
Market Data 
Markets 
AI
